Giampolo Merlini, MD
Giampaolo Merlini received his medical degree and specialized in Hematology and in Laboratory Medicine at the University of Pavia. He was trained by Prof. Jan Waldenström and Prof. Elliott Osserman in the study of monoclonal gammopathies and systemic amyloidosis. He is the Director of the Center for Research and Treatment of Systemic Amyloidosis, University Hospital Policlinico San Matteo, and the Director of Research of the University Hospital. He is full Professor of Clinical Biochemistry, Department of Molecular Medicine, University of Pavia, Italy. He was President of the International Society of Amyloidosis from 2005 to 2010.
Dr. Merlini’s research interests include the pathogenesis, natural history, diagnosis and treatment of monoclonal gammopathies, with particular focus on immunoglobulin light chain amyloidosis (AL). His recent research focuses on the investigation of biomarkers for early diagnosis, assessing prognosis and response to therapy and on the development of novel therapeutic agents and treatments designed in the light of advances in the understanding of the molecular mechanisms of AL amyloidosis. He is principal investigator for several clinical trials and research projects in this field.